|
Special Offers - for limited time only!!
£50 off total cost of treatment of 3 areas - just £250 for women and £300 for men (Areas are horizontal forehead lines, frown lines and crow's feet. Normally £300 (women) and £350 (men) for all 3 areas. Treatment undertaken between 01/07/10 - 31/07/10)
Not grade 2 or 3 (which provides minimal corrections) - £50 off second syringe (Normally £280 per syringe. You will pay only £230 for the second syringe. Offer ends 31/07/10)
FREE 2 tubes of medical skin care creams + SPF50 sun protection cream worth £120 Course of 4 peels £600 (offer ends 31/07/10)
News
US FDA data reveals low filler complications (January 2009 Issue) New US data has revealed that there is a 1:10,000 risk of complication with cosmetic filler injections. The US Physicians Coalition for Injectable Safety reported on new data compiled for the years 2003 through to present which, it said, demonstrated that the risk of adverse events such as swelling or cosmetic injection with US FDA approved dermal fillers number 0.010% or 1 in 10,000. The risk of injury is 0.009% or 1 in 11,000.
Injectables and weight loss procedures to dominate 2009 (January 2009 Issue) Non-surgical treatments are set to reach an increasingly diverse audience, according to the American Society for Aesthetic Plastic Surgery (ASAPS). The widening audience for aesthetic medicine will be lead by growing social acceptance of treatments and the development of more procedures that meet different needs, says the association. Other predictions include a growth in popularity of fillers as products evolve; and an accelerated growth in development of faster acting, less invasive treatments sparked by consumer demand.
The long-term use of Botox can reverse the ageing process, confirmed Dr Patrick Bowler in a new study.
The long-term use of botulinum toxin alters the ageing process in the upper face, according to a new study by consultant plastic surgeon Rajiv Grover. The study came about after Grover carried out several consultations with patients seeking a second facelift (some years after having the first with a different surgeon) and began to notice differences between those who had used botulinum toxin over several years and those who had not. By rebalancing the facial muscles it appears that botulinum toxin reduces the changes of drooping of the forehead and brow seen with ageing.
A television campaign for Juvederm® ULTRA has hit the small screen in both the UK and France and will continue to build over the next few weeks. A print advertising campaign has also been running in magazines including Marie Claire, Vogue, Elle and Hello. The television and print campaigns aim to raise awareness of Juvederm® ULTRA and advise patients on where they can find a qualified medical practitioner.
A recent study has found that 95% of patients preferred Juvederm® Ultra 3 as an injection experience over Restylane Perlane®. The study, a split-face comparison of two hyaluronic acid facial fillers in the treatment of naso-labial folds, involved 126 people. Subjects were blinded as to which side was injected with each product. The level of injection pain and ease of injection were assessed by the injectors while the patients assessed the level of injection pain and said whether they had a preference for one treatment over the other and, if so, why.
The male botulinum toxin industry was estimated to be worth £1m in 2007, with 20% of botulinum toxin patients being men. According to the figures, the number of men opting for the treatment has doubled over the last two years. Men are expected to be eternally youthful in terms of stamina and dynamism, but they are now being increasingly judged on their looks and are very aware of the importance of a good skin care regime in order to keep themselves fresh faced. And with more and more celebrities admitting to enhancing their looks, real men aren’t afraid to either and botox is no longer taboo.
|
Patients preferred Juvederm Ultra (June 2008 Issue)